Alvotech ALVO
NASDAQ ALVO
$4.17 +0.18 (+4.51%)
At close: Aug 20, 2026 · 2:09 PM UTC

Alvotech (ALVO) Net Income towards Common Stockholders (2021 - 2026)

Alvotech's (ALVO) quarterly Net Income towards Common Stockholders came in at $1.0 million in Q1 2026, down 99.06% YoY from $109.7 million in Q1 2025, and down 99.06% on a QoQ basis from $109.7 million in Q4 2025.

Alvotech (ALVO) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has 6 years of Net Income towards Common Stockholders data on file, last reported at $1.0 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 99.06% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$306.8 million (down 14.14% YoY) and the FY2025 annual result came in at $109.7 million, up 144.43% from the prior year.
  • Net Income towards Common Stockholders slipped to $1.0 million in Q1 2026, from $109.7 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $264.7 million in Q2 2022 to a low of -$651.1 million in Q4 2023.
  • A 5-year average of -$99.7 million and a median of -$58.9 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders tumbled 362.17% — and 2025, when it jumped 51566.14%.
  • Tracing ALVO's Net Income towards Common Stockholders over 5 years: stood at -$540.7 million in 2022, then declined by 20.43% to -$651.1 million in 2023, then surged by 65.69% to -$223.4 million in 2024, then jumped by 149.1% to $109.7 million in 2025, then plunged by 99.06% to $1.0 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $1.0 million (Q1 2026), $109.7 million (Q4 2025), and -$307.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 43.87 Bn 42.91 Bn - -
2 Teva Pharmaceutical Industries 43.00 Bn 39.35 Bn 2.15 Bn -576.00 Mn
3 Zoetis 31.59 Bn 29.92 Bn 1.05 Bn 866.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 710.19 Mn
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn 333.00 Mn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -118.80 Mn
7 Neurocrine Biosciences 15.55 Bn 15.16 Bn 935.80 Mn 144.40 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 54.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Alvotech 1.23 Bn 1.23 Bn 5.09 Mn 1.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Mn
Dec 31, 2025 109.68 Mn
Sep 30, 2025 -307.87 Mn
Jun 30, 2025 -109.68 Mn
Mar 31, 2025 109.68 Mn
Dec 31, 2024 -223.39 Mn
Sep 30, 2024 -303.58 Mn
Jun 30, 2024 148.46 Mn
Mar 31, 2024 -213,111.00
Dec 31, 2023 -651.14 Mn
Aug 31, 2023 -86.85 Mn
Jun 30, 2023 138.48 Mn
Mar 31, 2023 -246,152.00
Dec 31, 2022 -540.69 Mn
Aug 31, 2022 -184.47 Mn
Jun 30, 2022 264.69 Mn
Mar 31, 2022 -58.90 Mn
Dec 31, 2021 206.23 Mn
Sep 30, 2021 -33.79 Mn